Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 04, 2019 08:03 ET | Source: BioDelivery Sciences International, Inc.

BioDelivery Announces Expanded Preferred Insurance Coverage For BELBUCA®

RALEIGH, N.C., Feb. 04, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients...
January 15, 2019 07:30 ET | Source: BioDelivery Sciences International, Inc.

BioDelivery Sciences Appoints Terry Coelho as Chief Financial Officer

RALEIGH, N.C., Jan. 15, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients...
May 22, 2018 08:29 ET | Source: BioDelivery Sciences International, Inc.

BioDelivery Sciences Announces Closing of $50 Million Equity Financing and Appointment of Peter Greenleaf as Chairman of the Board

RALEIGH, N.C., May 22, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ:BDSI) today announced it has closed its previously announced $50 million registered direct offering...
May 17, 2018 08:01 ET | Source: BioDelivery Sciences International, Inc.

BioDelivery Sciences Announces Agreement with Broadfin Capital on Comprehensive Plan to Strengthen Business

$50 Million Equity Financing Led By Broadfin Announced Separately Today Three New Independent Directors Selected by Broadfin Added To Board; Four Current Independent Directors Retiring Amends...
May 17, 2018 08:01 ET | Source: BioDelivery Sciences International, Inc.

BioDelivery Sciences Announces Pricing of $50 Million Equity Financing

RALEIGH, N.C., May 17, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ:BDSI) today announced that it has entered into definitive agreements with existing institutional and...